These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2346615)

  • 1. Inhibitory effects of cholecystokinin develop through interaction with duodenal signals.
    Cox JE
    Behav Brain Res; 1990 Apr; 38(1):35-44. PubMed ID: 2346615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin interacts with prefeeding to impair runway performance.
    Cox JE
    Behav Brain Res; 1986 Jul; 21(1):29-36. PubMed ID: 3741594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent interaction between cholecystokinin and sham feeding.
    Cox JE; Smith MJ
    Behav Brain Res; 1987; 26(2-3):109-17. PubMed ID: 3426784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of cholecystokinin in impairing runway performance.
    Cox JE; Brown PT; Toney RJ; Wiebe DJ
    Behav Brain Res; 1984 Oct; 14(1):41-50. PubMed ID: 6097286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK inhibits real and sham feeding in gastric vagotomized rats.
    Le Sauter J; Goldberg B; Geary N
    Physiol Behav; 1988; 44(4-5):527-34. PubMed ID: 3237842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal sucrose and glucose infusions enhance suppression by cholecystokinin of sham feeding.
    Cox JE
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R466-71. PubMed ID: 8141404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic-portal infusion reduces the satiating potency of CCK-8.
    Greenberg D; Smith GP
    Physiol Behav; 1988; 44(4-5):535-8. PubMed ID: 3237843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholecystokinin on taste preference and sensitivity in rats.
    Gosnell BA; Hsiao S
    Behav Neurosci; 1984 Jun; 98(3):452-60. PubMed ID: 6329243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man.
    Muurahainen N; Kissileff HR; Derogatis AJ; Pi-Sunyer FX
    Physiol Behav; 1988; 44(4-5):645-9. PubMed ID: 3237850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of sucrose intake by continuous near-celiac and intravenous cholecystokinin infusions in rats.
    Cox JE; Perdue GS; Tyler WJ
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R150-5. PubMed ID: 7840316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of oropharyngeal stimulation in cholecystokinin-induced satiety in the sham feeding rat.
    Forsyth PA; Weingarten HP; Collins SM
    Physiol Behav; 1985 Oct; 35(4):539-43. PubMed ID: 4070427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of satiety by a cholecystokinin antagonist is independent of gastric emptying.
    Collins SM; Weingarten HP
    Peptides; 1984; 5(3):481-4. PubMed ID: 6089141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pyloric cuffs on cholecystokinin satiety.
    Cox JE
    Physiol Behav; 1996 Sep; 60(3):1023-6. PubMed ID: 8873286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical investigation of the afferent pathway from the vagus nerve to the nucleus tractus solitarius in mediating the "satiety syndrome" induced by systemic cholecystokinin.
    Crawley JN
    Peptides; 1985; 6 Suppl 1():133-7. PubMed ID: 4047976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gastric distention in cholecystokinin's satiety effect in golden hamsters.
    Miceli MO
    Physiol Behav; 1985 Dec; 35(6):945-53. PubMed ID: 4095187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation.
    Eisen S; Phillips RJ; Geary N; Baronowsky EA; Powley TL; Smith GP
    Am J Physiol Regul Integr Comp Physiol; 2005 Aug; 289(2):R456-R462. PubMed ID: 15831770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
    Gutzwiller JP; Drewe J; Ketterer S; Hildebrand P; Krautheim A; Beglinger C
    Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R189-95. PubMed ID: 10896881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
    Gourcerol G; Wang L; Wang YH; Million M; Taché Y
    Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
    Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Baba S
    Brain Res; 1987 Aug; 417(2):355-9. PubMed ID: 3651819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholecystokinin and caerulein on human eating behavior and pain sensation: a review.
    Stacher G
    Psychoneuroendocrinology; 1986; 11(1):39-48. PubMed ID: 3085129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.